DT-010709

N/A

Report date: 2025/06/11 11:29:18
NME

Base Information

Drug NameDT-010709
Drug Alias NamemGluR3 PAM (Mavalon Therapeutics)mGluR3 PAM (Domain Therapeutics)mGluR3 modulators (Prexton)DT-2208DT-010709
ClassificationSmall molecules
Mechanisms of ActionMetabotropic glutamate receptor 3 modulators
TargetsMetabotropic glutamate receptor 3
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDomain Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesMavalon Therapeutics Ltd
Inactive CompaniesDomain Therapeutics SA
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A